Add Company
Join Now

RhythMedix Revenue and Competitors

License our Company Data API

Mt. Laurel, NJ USA

Location

N/A

Total Funding

Medical

Industry

Estimated Revenue & Valuation

  • RhythMedix's estimated annual revenue is currently $7.5M per year.(i)
  • RhythMedix's estimated revenue per employee is $70,093

Employee Data

  • RhythMedix has 107 Employees.(i)
  • RhythMedix grew their employee count by 22% last year.

RhythMedix's People

NameTitleEmail/Phone
1
Co-Founder, President & COOReveal Email/Phone
2
CTO & Co-FounderReveal Email/Phone
3
SVP, Business Development and StrategyReveal Email/Phone
4
VP, Payer RelationsReveal Email/Phone
5
SVP SalesReveal Email/Phone
6
SVP, Clinical OperationsReveal Email/Phone
7
VP Regulatory and QualityReveal Email/Phone
8
Chief Financial OfficerReveal Email/Phone
9
Director Federal SalesReveal Email/Phone
10
Chief Information OfficerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
N/A306-6%N/AN/A
#2
$3.5M633%N/AN/A
#3
N/A1276%N/AN/A
#4
N/A46329%N/AN/A
#5
N/A1250%N/AN/A
#6
$7.5M10722%N/AN/A
#7
N/A1271%N/AN/A
#8
$1.7M176%N/AN/A
#9
N/A350%N/AN/A
#10
N/A3934%N/AN/A
Add Company

What Is RhythMedix?

RhythMedix® provides innovative technology to transform the medical monitoring industry and improve patient outcomes. The connected RhythmStar® System provides the first and only wearable multi-modality cardiac monitoring (Holter, Event and MCT) device that continuously and discreetly connects patients and clinicians via built-in 4G cellular technology for improved patient care. Powerful cloud-based algorithms evaluate every heartbeat and empower physicians with timely and actionable reporting that is verified by a RhythMedix US-based certified technician.

keywords:N/A

N/A

Total Funding

107

Number of Employees

$7.5M

Revenue (est)

22%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$17M11310%N/A
#2
$35M12912%N/A
#3
$25.5M193-3%N/A
#4
$59.2M299-9%N/A
#5
$180.4M65610%N/A